EUVIMEDEUVIMED entdecken
Crossref

Sodium‐Glucose Cotransporter‐2 Inhibitor Suppresses Endoplasmic Reticulum Stress and Oxidative Stress in Diabetic Nephropathy Through Nrf2 Signaling: A Clinical and Experimental Study

Murali Krishna Prasad, Paul S Victor, Goutham V Ganesh, Udayama Juttada, Satyavani Kumpatla, Vijay Viswanathan, Kunka Mohanram Ramkumar

The Journal of Clinical Pharmacology · 2024

DOI: 10.1002/jcph.2465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, 2024. Verfasst von Murali Krishna Prasad und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamilnadu, India. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Sodium-Glucose Transporter 2 Inhibitors, Diabetic Nephropathies, Endoplasmic Reticulum Stress. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic nephropathy (DN), a severe complication of type 2 diabetes mellitus (T2DM), is marked by heightened endoplasmic reticulum stress (ERS) and oxidative stress (OS) due to protein misfolding and free radical generation. We investigated the sodium‐glucose co‐transporter‐2 inhibitor (SGLT2i), canagliflozin (Cana), in alleviating ERS and OS in DN patients and THP‐1 cells under hyperglycemic condition. A total of 120 subjects were divided into four groups, with 30 subjects in each group: healthy controls, T2DM individuals, DN patients receiving standard treatment, and those treated with Cana. The control group had no history of diabetes, cardiovascular or renal diseases, or other comorbidities. Cana was administered at doses of either 100 or 300 mg per day based on the estimated glomerular filtration rate (eGFR) value of DN individuals, with a mean follow‐up of 6 months. Additionally, THP‐1 monocytes were exposed to HGM (33.3 mM glucose with a cytokine cocktail of TNF‐α and IFN‐γ at 50 ng/mL each) to evaluate the relative levels of ERS, OS markers, and nuclear factor erythroid 2‐related factor 2 (Nrf2), the transcription factor regulating cellular redox, which is downregulated in diabetes. Our results revealed that ERS markers GRP78 and PERK, as well as OS markers TXNIP and p22phox, were elevated in both DN patients and HGM‐treated THP‐1 monocytes and were reduced by Cana intervention. Furthermore, Cana regulated the phosphorylation of Nrf2, Akt, and EIF2α in HGM‐treated monocytes. In conclusion, our findings highlight the role of Cana in activating Nrf2, thereby attenuating ERS and OS to mitigate DN progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2Sodium-Glucose Transporter 2 InhibitorsDiabetic NephropathiesEndoplasmic Reticulum StressOxidative StressEndoplasmic Reticulum Chaperone BiPSignal TransductionDiabetes Mellitus, Type 2CanagliflozinHumansMaleMiddle AgedFemaleAgedTHP-1 CellsAdult

Stichwörter der Autor:innen

Diabetic nephropathyNrf2THP‐1 monocytescanagliflozinendoplasmic reticulum stress

Substanzen

NF-E2-Related Factor 2Sodium-Glucose Transporter 2 InhibitorsNFE2L2 protein, humanHSPA5 protein, humanEndoplasmic Reticulum Chaperone BiPCanagliflozin

Autor:innen und Institutionen

  • Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamilnadu, India.
  • Department of Biochemistry and Molecular Genetics, Prof. M. Viswanathan's Diabetes Research Center, M.V. Hospital for Diabetes, Royapuram Chennai, Tamilnadu, India.

Förderung

  • Department of Biotechnology, School of Bioengineering
  • SRM Institute of Science and Technology

Zitieren

APA

Prasad, M. K., Victor, P. S., Ganesh, G. V., Juttada, U., Kumpatla, S., Viswanathan, V., & Ramkumar, K. M. (2024). Sodium‐Glucose Cotransporter‐2 Inhibitor Suppresses Endoplasmic Reticulum Stress and Oxidative Stress in Diabetic Nephropathy Through Nrf2 Signaling: A Clinical and Experimental Study. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.2465

Vancouver

Prasad MK, Victor PS, Ganesh GV, Juttada U, Kumpatla S, Viswanathan V, et al. Sodium‐Glucose Cotransporter‐2 Inhibitor Suppresses Endoplasmic Reticulum Stress and Oxidative Stress in Diabetic Nephropathy Through Nrf2 Signaling: A Clinical and Experimental Study. The Journal of Clinical Pharmacology. 2024. doi:10.1002/jcph.2465

BibTeX
@article{Prasad2024,
  author = {Prasad, Murali Krishna and Victor, Paul S and Ganesh, Goutham V and Juttada, Udayama and Kumpatla, Satyavani and Viswanathan, Vijay and Ramkumar, Kunka Mohanram},
  title = {Sodium‐Glucose Cotransporter‐2 Inhibitor Suppresses Endoplasmic Reticulum Stress and Oxidative Stress in Diabetic Nephropathy Through Nrf2 Signaling: A Clinical and Experimental Study},
  journal = {The Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1002/jcph.2465}
}
Kostenlos starten →